A Study to See if New Device Technology Can Tell the Difference Between Non-cancer and Cancerous Melanoma


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Scottsdale/Phoenix, Arizona: 13-008351
    Sponsor Protocol Number: 13-008351

About this study

The purpose of this study is to use new technology called Optical Transfer Diagnosis (OTD) to find if skin lesions are melanomas or non cancer. The research study team wants to see if the Balter Medical OTD technology will identify these lesions the same or better than a dermatologist.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • A total of 300 patients in sets of 50 patients
  • Individuals capable of giving informed consent
  • Over the age of 17
  • Biopsy or excision of suspicious pigmented lesions is planned
  • Women who are pregnant and/or nursing may take part in this study

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

David Swanson, M.D.

Closed for enrollment

Contact information:

Shanann Avelar




Mayo Clinic Footer